"The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections.
Orbactiv is approved to treat patients with acute bacterial skin and skin structure infections (ABSS"...
Halonate Side Effects Center
Medical Editor: Charles Patrick Davis, MD, PhD
Halonate (halobetasol propionate) ointment is a super-high potency corticosteroid indicated for the relief of the inflammatory and pruritic (itchy) manifestations. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within two weeks, reassessment of the diagnosis may be necessary. Halonate is not available in the US as a generic. The most frequent adverse events reported for Halonate include stinging and burning.
Halobetasol Propionate Ointment contains 0.05% strength of halobetasol propionate and is available in a 50g tube. Treatment beyond two consecutive weeks is not recommended and the total dosage should not exceed 50 g/week. Patients should apply a thin layer of Halonate ointment to the affected skin once or twice daily, as directed by a physician, and rub in gently and completely. The drug should not be used should not be used on the face, groin or in the axillae. Serious side effects include acne, skin infections, Cushing's syndrome and hyperglycemia. There are no adequate and well-controlled studies of Halonate in pregnant women. Halonate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Because many drugs are excreted in human milk, caution should be exercised when Halonate ointment is administered to a nursing woman. Use in children under 12 years old is not recommended.
Our Halonate Ointment Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Halonate FDA Prescribing Information: Side Effects
In controlled clinical trials, the most frequent adverse events reported for Halobetasol Propionate Ointment included stinging or burning in 1.6% of the patients Less frequently reported adverse reactions were postulation, erythema, skin atrophy, leukoderma, acne, itching, secondary infection, telangiectasia, urticaria, dry skin, miliaria, paresthesia, and rash.
The following additional local adverse reactions are reported infrequently with topical corticosteroids, and they may occur more frequently with high potency corticosteroids, such as Halobetasol Propionate Ointment. These reactions are listed in an approximate decreasing order of occurrence: folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae and miliaria.
Read the entire FDA prescribing information for Halonate (Halobetasol Propionate Ointment)
Additional Halonate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.